

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.71097813 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.25291027 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.14139253 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.14139253 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 5.03432177 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.97379913 |
| 7 | positive thymic T cell selection (GO:0045059) | 4.77598111 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.74223541 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.70185976 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.70185976 |
| 11 | B cell receptor signaling pathway (GO:0050853) | 4.66682962 |
| 12 | positive regulation of B cell differentiation (GO:0045579) | 4.37993435 |
| 13 | detection of other organism (GO:0098543) | 4.24185189 |
| 14 | detection of bacterium (GO:0016045) | 4.21438124 |
| 15 | regulation of B cell differentiation (GO:0045577) | 4.06791966 |
| 16 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.01527367 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 3.98563099 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 3.98563099 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.98563099 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.98563099 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.98563099 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.98563099 |
| 23 | negative thymic T cell selection (GO:0045060) | 3.87935018 |
| 24 | germinal center formation (GO:0002467) | 3.84620085 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.81902911 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.80609509 |
| 27 | mannose metabolic process (GO:0006013) | 3.78829436 |
| 28 | positive T cell selection (GO:0043368) | 3.77821699 |
| 29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.76513736 |
| 30 | negative T cell selection (GO:0043383) | 3.74025478 |
| 31 | thymic T cell selection (GO:0045061) | 3.73344952 |
| 32 | mature B cell differentiation (GO:0002335) | 3.65597695 |
| 33 | response to interleukin-15 (GO:0070672) | 3.60584977 |
| 34 | T cell selection (GO:0045058) | 3.52659488 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 3.48726797 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.46896729 |
| 37 | cellular response to zinc ion (GO:0071294) | 3.43796620 |
| 38 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.41141444 |
| 39 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.40079517 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.38606589 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 3.37765651 |
| 42 | negative regulation of T cell mediated immunity (GO:0002710) | 3.34199542 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 3.33173875 |
| 44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.30879101 |
| 45 | regulation of mast cell degranulation (GO:0043304) | 3.30504130 |
| 46 | T cell migration (GO:0072678) | 3.27987067 |
| 47 | tolerance induction (GO:0002507) | 3.27640591 |
| 48 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.24602839 |
| 49 | regulation of leukocyte degranulation (GO:0043300) | 3.23526136 |
| 50 | neutrophil activation involved in immune response (GO:0002283) | 3.21149380 |
| 51 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.20677662 |
| 52 | defense response to protozoan (GO:0042832) | 3.17648656 |
| 53 | cellular extravasation (GO:0045123) | 3.17175928 |
| 54 | leukocyte aggregation (GO:0070486) | 3.16903786 |
| 55 | positive regulation of antigen processing and presentation (GO:0002579) | 3.14612387 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.12049492 |
| 57 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10677384 |
| 58 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.05447952 |
| 59 | myeloid dendritic cell activation (GO:0001773) | 3.03635707 |
| 60 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.03630639 |
| 61 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00687433 |
| 62 | detection of biotic stimulus (GO:0009595) | 3.00266766 |
| 63 | cellular response to interleukin-15 (GO:0071350) | 2.99450873 |
| 64 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.99136547 |
| 65 | myeloid dendritic cell differentiation (GO:0043011) | 2.97009125 |
| 66 | neutrophil activation (GO:0042119) | 2.96142482 |
| 67 | positive regulation of Rap GTPase activity (GO:0032854) | 2.95052373 |
| 68 | positive regulation of interferon-alpha production (GO:0032727) | 2.94017009 |
| 69 | myeloid cell activation involved in immune response (GO:0002275) | 2.93839883 |
| 70 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.92571225 |
| 71 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.90494282 |
| 72 | B cell homeostasis (GO:0001782) | 2.89947944 |
| 73 | respiratory burst (GO:0045730) | 2.89370703 |
| 74 | regulation of interferon-alpha production (GO:0032647) | 2.88878883 |
| 75 | natural killer cell differentiation (GO:0001779) | 2.86327941 |
| 76 | positive regulation of interleukin-2 production (GO:0032743) | 2.86009143 |
| 77 | negative regulation of interleukin-12 production (GO:0032695) | 2.85726955 |
| 78 | detection of molecule of bacterial origin (GO:0032490) | 2.85106158 |
| 79 | response to protozoan (GO:0001562) | 2.84374431 |
| 80 | positive regulation of histone deacetylation (GO:0031065) | 2.82988219 |
| 81 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.82932431 |
| 82 | T cell homeostasis (GO:0043029) | 2.82660900 |
| 83 | granulocyte activation (GO:0036230) | 2.82002480 |
| 84 | lymphocyte homeostasis (GO:0002260) | 2.79870686 |
| 85 | negative regulation of granulocyte differentiation (GO:0030853) | 2.79743463 |
| 86 | regulation of regulated secretory pathway (GO:1903305) | 2.79158282 |
| 87 | B cell proliferation (GO:0042100) | 2.78905099 |
| 88 | Peyers patch development (GO:0048541) | 2.74007399 |
| 89 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.74007399 |
| 90 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.73905890 |
| 91 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.72690491 |
| 92 | mast cell activation (GO:0045576) | 2.70271754 |
| 93 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.69002293 |
| 94 | signal complex assembly (GO:0007172) | 2.68921549 |
| 95 | regulation of ARF protein signal transduction (GO:0032012) | 2.68873484 |
| 96 | response to laminar fluid shear stress (GO:0034616) | 2.67599468 |
| 97 | negative regulation of innate immune response (GO:0045824) | 2.67182980 |
| 98 | histone H3-K36 demethylation (GO:0070544) | 2.65923652 |
| 99 | macrophage activation (GO:0042116) | 2.65642318 |
| 100 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.64509222 |
| 101 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.64509222 |
| 102 | activated T cell proliferation (GO:0050798) | 2.64456422 |
| 103 | regulation of tolerance induction (GO:0002643) | 2.63971866 |
| 104 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.62347101 |
| 105 | positive regulation of mast cell activation (GO:0033005) | 2.61418448 |
| 106 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.61213575 |
| 107 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.61060358 |
| 108 | mature B cell differentiation involved in immune response (GO:0002313) | 2.60332307 |
| 109 | leukocyte cell-cell adhesion (GO:0007159) | 2.59999564 |
| 110 | response to type I interferon (GO:0034340) | 2.58228749 |
| 111 | response to peptidoglycan (GO:0032494) | 2.57047675 |
| 112 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.56565437 |
| 113 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.56547413 |
| 114 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.56170355 |
| 115 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.55241367 |
| 116 | response to host immune response (GO:0052572) | 2.55241367 |
| 117 | activation of JUN kinase activity (GO:0007257) | 2.54231875 |
| 118 | negative regulation of B cell proliferation (GO:0030889) | 2.53911757 |
| 119 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.53482430 |
| 120 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.53181387 |
| 121 | negative regulation of phagocytosis (GO:0050765) | 2.53099712 |
| 122 | negative regulation of interleukin-6 production (GO:0032715) | 2.52823665 |
| 123 | cellular response to type I interferon (GO:0071357) | 2.52009428 |
| 124 | type I interferon signaling pathway (GO:0060337) | 2.52009428 |
| 125 | regulation of regulatory T cell differentiation (GO:0045589) | 2.51070245 |
| 126 | T cell proliferation (GO:0042098) | 2.50358876 |
| 127 | regulation of T cell tolerance induction (GO:0002664) | 2.50294493 |
| 128 | T cell receptor signaling pathway (GO:0050852) | 2.49698712 |
| 129 | T cell costimulation (GO:0031295) | 2.48321033 |
| 130 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.47996360 |
| 131 | response to host (GO:0075136) | 2.47996360 |
| 132 | response to host defenses (GO:0052200) | 2.47996360 |
| 133 | regulation of B cell proliferation (GO:0030888) | 2.47662781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.79027980 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.66144501 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.43716064 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.85465280 |
| 5 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.61037020 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.37905635 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.36083314 |
| 8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.17487521 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.11277341 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.08896755 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.90109329 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.89390374 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.85419199 |
| 14 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.84148826 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.79018689 |
| 16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71137475 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.60378969 |
| 18 | * MAF_26560356_Chip-Seq_TH1_Human | 2.56271583 |
| 19 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.55220781 |
| 20 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49841868 |
| 21 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46445662 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.45277024 |
| 23 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.41235010 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.39779412 |
| 25 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.37484582 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37408312 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.36106117 |
| 28 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.33953870 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.32515580 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 2.24531721 |
| 31 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.17833371 |
| 32 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.13619662 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07097282 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06786210 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06462812 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.05055631 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02217659 |
| 38 | * MYB_26560356_Chip-Seq_TH1_Human | 1.97683896 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95162184 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89817054 |
| 41 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.80509761 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.75824950 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64680748 |
| 44 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.61340032 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60600862 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.60448610 |
| 47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.57544835 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.57124634 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54194892 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.50970230 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.49603799 |
| 52 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.49063885 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45830726 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44276806 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39162302 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38600772 |
| 57 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.38507799 |
| 58 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.36038714 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34166477 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32864475 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32244370 |
| 62 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31865876 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31395605 |
| 64 | * P68_20966046_ChIP-Seq_HELA_Human | 1.29129045 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24272805 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24042701 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22592037 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22405864 |
| 69 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21686308 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20096650 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18913180 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16212652 |
| 73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15416197 |
| 74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13017672 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12426514 |
| 76 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09970140 |
| 77 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09307569 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07462622 |
| 79 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07291457 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07138149 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06955101 |
| 82 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06564597 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06245424 |
| 84 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03456515 |
| 85 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03398971 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02706828 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01498477 |
| 88 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01017826 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99789798 |
| 90 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99500456 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98314765 |
| 92 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97389903 |
| 93 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.97218122 |
| 94 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97156466 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97049789 |
| 96 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96841734 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95715670 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95101075 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95101075 |
| 100 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94958455 |
| 101 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92398276 |
| 102 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.92394444 |
| 103 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91780089 |
| 104 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89289898 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89278140 |
| 106 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88510346 |
| 107 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88505641 |
| 108 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87209917 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87042048 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86670696 |
| 111 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86538201 |
| 112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85397130 |
| 113 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.85011888 |
| 114 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83082613 |
| 115 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83066848 |
| 116 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81480090 |
| 117 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79647806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.88272234 |
| 2 | MP0004510_myositis | 3.48317517 |
| 3 | MP0003303_peritoneal_inflammation | 3.42340628 |
| 4 | MP0005387_immune_system_phenotype | 3.25557440 |
| 5 | MP0001790_abnormal_immune_system | 3.25557440 |
| 6 | MP0001800_abnormal_humoral_immune | 3.18890808 |
| 7 | MP0000685_abnormal_immune_system | 2.97570855 |
| 8 | MP0005671_abnormal_response_to | 2.72726952 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.70858759 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.64442418 |
| 11 | MP0003436_decreased_susceptibility_to | 2.58420325 |
| 12 | MP0005451_abnormal_body_composition | 2.54929860 |
| 13 | MP0002723_abnormal_immune_serum | 2.48799743 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.39022384 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.36150011 |
| 16 | MP0003646_muscle_fatigue | 2.35318013 |
| 17 | MP0001819_abnormal_immune_cell | 2.32358336 |
| 18 | MP0002419_abnormal_innate_immunity | 2.25366979 |
| 19 | MP0005025_abnormal_response_to | 2.18961318 |
| 20 | MP0002398_abnormal_bone_marrow | 2.11700914 |
| 21 | MP0008260_abnormal_autophagy | 2.08638396 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.07804206 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.03361995 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.99190092 |
| 25 | MP0009785_altered_susceptibility_to | 1.96460716 |
| 26 | MP0002396_abnormal_hematopoietic_system | 1.96019671 |
| 27 | MP0000716_abnormal_immune_system | 1.95482731 |
| 28 | MP0009278_abnormal_bone_marrow | 1.95014836 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.85737791 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.81667330 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.81130393 |
| 32 | MP0002405_respiratory_system_inflammati | 1.78891267 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.78257803 |
| 34 | MP0001853_heart_inflammation | 1.73295783 |
| 35 | MP0001873_stomach_inflammation | 1.72146838 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.70318325 |
| 37 | MP0002722_abnormal_immune_system | 1.66530382 |
| 38 | MP0006082_CNS_inflammation | 1.63607985 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.60694012 |
| 40 | MP0000751_myopathy | 1.60394265 |
| 41 | MP0002429_abnormal_blood_cell | 1.57985712 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.57803688 |
| 43 | MP0004947_skin_inflammation | 1.57740205 |
| 44 | MP0004036_abnormal_muscle_relaxation | 1.55234484 |
| 45 | MP0004381_abnormal_hair_follicle | 1.51556482 |
| 46 | MP0004130_abnormal_muscle_cell | 1.45645364 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.43963509 |
| 48 | MP0000858_altered_metastatic_potential | 1.43919144 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.43811607 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.42414344 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.40311738 |
| 52 | MP0002006_tumorigenesis | 1.38118592 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.37920324 |
| 54 | MP0004084_abnormal_cardiac_muscle | 1.36558391 |
| 55 | MP0000749_muscle_degeneration | 1.31443466 |
| 56 | MP0003866_abnormal_defecation | 1.30094515 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.26841103 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.26841103 |
| 59 | MP0005310_abnormal_salivary_gland | 1.24924832 |
| 60 | MP0004087_abnormal_muscle_fiber | 1.21638168 |
| 61 | MP0002106_abnormal_muscle_physiology | 1.20419352 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.15840567 |
| 63 | MP0003828_pulmonary_edema | 1.15634162 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.14118989 |
| 65 | MP0009333_abnormal_splenocyte_physiolog | 1.12684702 |
| 66 | MP0003075_altered_response_to | 1.11351803 |
| 67 | MP0000343_altered_response_to | 1.11329083 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.10682705 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.10543787 |
| 70 | MP0004145_abnormal_muscle_electrophysio | 1.07977580 |
| 71 | MP0000747_muscle_weakness | 1.07856210 |
| 72 | MP0009840_abnormal_foam_cell | 1.07109694 |
| 73 | MP0002132_abnormal_respiratory_system | 1.05532837 |
| 74 | MP0010630_abnormal_cardiac_muscle | 1.03393273 |
| 75 | MP0002009_preneoplasia | 1.02839696 |
| 76 | MP0001849_ear_inflammation | 1.02181911 |
| 77 | MP0000604_amyloidosis | 1.02149407 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.01792743 |
| 79 | MP0008469_abnormal_protein_level | 1.00772039 |
| 80 | MP0005076_abnormal_cell_differentiation | 0.98205133 |
| 81 | MP0002933_joint_inflammation | 0.97655242 |
| 82 | MP0005666_abnormal_adipose_tissue | 0.96623178 |
| 83 | MP0004859_abnormal_synaptic_plasticity | 0.92619935 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.91643853 |
| 85 | MP0000750_abnormal_muscle_regeneration | 0.89333253 |
| 86 | MP0000759_abnormal_skeletal_muscle | 0.89057176 |
| 87 | MP0003448_altered_tumor_morphology | 0.88361223 |
| 88 | MP0003690_abnormal_glial_cell | 0.87976850 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.87357784 |
| 90 | MP0001851_eye_inflammation | 0.87270875 |
| 91 | MP0005166_decreased_susceptibility_to | 0.83518227 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.83410652 |
| 93 | MP0003724_increased_susceptibility_to | 0.80941989 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.80431738 |
| 95 | MP0005330_cardiomyopathy | 0.80320251 |
| 96 | MP0005369_muscle_phenotype | 0.79614865 |
| 97 | MP0001348_abnormal_lacrimal_gland | 0.79547259 |
| 98 | MP0008569_lethality_at_weaning | 0.78840985 |
| 99 | MP0002877_abnormal_melanocyte_morpholog | 0.78586472 |
| 100 | MP0003329_amyloid_beta_deposits | 0.77860777 |
| 101 | MP0003045_fibrosis | 0.77439722 |
| 102 | MP0008874_decreased_physiological_sensi | 0.76130432 |
| 103 | MP0000733_abnormal_muscle_development | 0.75167689 |
| 104 | MP0000490_abnormal_crypts_of | 0.74650505 |
| 105 | MP0004484_altered_response_of | 0.74350546 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.73650346 |
| 107 | MP0003091_abnormal_cell_migration | 0.73600804 |
| 108 | MP0004215_abnormal_myocardial_fiber | 0.73389057 |
| 109 | MP0009764_decreased_sensitivity_to | 0.71486848 |
| 110 | MP0001544_abnormal_cardiovascular_syste | 0.70837302 |
| 111 | MP0005385_cardiovascular_system_phenoty | 0.70837302 |
| 112 | MP0002269_muscular_atrophy | 0.70510375 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 0.70020353 |
| 114 | MP0005390_skeleton_phenotype | 0.68918335 |
| 115 | MP0004883_abnormal_blood_vessel | 0.68902826 |
| 116 | MP0002972_abnormal_cardiac_muscle | 0.68420553 |
| 117 | MP0010307_abnormal_tumor_latency | 0.67281824 |
| 118 | MP0003191_abnormal_cellular_cholesterol | 0.67005643 |
| 119 | MP0005409_darkened_coat_color | 0.66390165 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.65863069 |
| 121 | MP0001663_abnormal_digestive_system | 0.65125921 |
| 122 | MP0002138_abnormal_hepatobiliary_system | 0.64344608 |
| 123 | MP0004858_abnormal_nervous_system | 0.64217164 |
| 124 | MP0005621_abnormal_cell_physiology | 0.64143826 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.63322643 |
| 126 | MP0000920_abnormal_myelination | 0.62836906 |
| 127 | MP0003795_abnormal_bone_structure | 0.62436438 |
| 128 | MP0000249_abnormal_blood_vessel | 0.58395914 |
| 129 | MP0002019_abnormal_tumor_incidence | 0.57713070 |
| 130 | MP0009763_increased_sensitivity_to | 0.57240009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.76352787 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.26291720 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.13570328 |
| 4 | Recurrent viral infections (HP:0004429) | 4.01316040 |
| 5 | Agammaglobulinemia (HP:0004432) | 3.97453957 |
| 6 | Colitis (HP:0002583) | 3.89314449 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.81490693 |
| 8 | Inflammation of the large intestine (HP:0002037) | 3.80510183 |
| 9 | Cellulitis (HP:0100658) | 3.79419327 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.69983157 |
| 11 | Gastrointestinal inflammation (HP:0004386) | 3.64320001 |
| 12 | Gastrointestinal stroma tumor (HP:0100723) | 3.62134883 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.52284498 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.51631576 |
| 15 | Recurrent bronchitis (HP:0002837) | 3.45072731 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.42075952 |
| 17 | Chronic otitis media (HP:0000389) | 3.36897820 |
| 18 | Exercise-induced myalgia (HP:0003738) | 3.32627592 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.30950455 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.30950455 |
| 21 | Meningitis (HP:0001287) | 3.21343875 |
| 22 | IgM deficiency (HP:0002850) | 3.17638779 |
| 23 | Recurrent skin infections (HP:0001581) | 3.15461158 |
| 24 | Myositis (HP:0100614) | 3.15040306 |
| 25 | Spontaneous hematomas (HP:0007420) | 3.08006038 |
| 26 | Vasculitis (HP:0002633) | 3.05229587 |
| 27 | Exercise-induced muscle cramps (HP:0003710) | 3.04195599 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 2.99115381 |
| 29 | Nasal polyposis (HP:0100582) | 2.97040923 |
| 30 | Stomatitis (HP:0010280) | 2.96449051 |
| 31 | Papilloma (HP:0012740) | 2.95474403 |
| 32 | Verrucae (HP:0200043) | 2.95474403 |
| 33 | T lymphocytopenia (HP:0005403) | 2.86402968 |
| 34 | Abnormality of the fingertips (HP:0001211) | 2.78059963 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 2.75636826 |
| 36 | Frequent falls (HP:0002359) | 2.74363156 |
| 37 | Abnormality of T cell number (HP:0011839) | 2.74305430 |
| 38 | Encephalitis (HP:0002383) | 2.70343354 |
| 39 | Obstructive sleep apnea (HP:0002870) | 2.70316175 |
| 40 | Abnormality of the nasal mucosa (HP:0000433) | 2.70114445 |
| 41 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.69587198 |
| 42 | Chest pain (HP:0100749) | 2.68214817 |
| 43 | Hematochezia (HP:0002573) | 2.68171833 |
| 44 | Calf muscle hypertrophy (HP:0008981) | 2.66715432 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.66229489 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.65534920 |
| 47 | Obstructive lung disease (HP:0006536) | 2.65534920 |
| 48 | Emphysema (HP:0002097) | 2.64233250 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61227276 |
| 50 | Restrictive lung disease (HP:0002091) | 2.57831395 |
| 51 | Lymphopenia (HP:0001888) | 2.56574964 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.54044661 |
| 53 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.50375221 |
| 54 | Recurrent sinusitis (HP:0011108) | 2.49375433 |
| 55 | Difficulty running (HP:0009046) | 2.45690254 |
| 56 | Pustule (HP:0200039) | 2.45447988 |
| 57 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.45137051 |
| 58 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.44328723 |
| 59 | Subaortic stenosis (HP:0001682) | 2.44328723 |
| 60 | Abnormality of macrophages (HP:0004311) | 2.44050355 |
| 61 | Abnormality of T cells (HP:0002843) | 2.43515258 |
| 62 | Thyroiditis (HP:0100646) | 2.43305327 |
| 63 | Dysostosis multiplex (HP:0000943) | 2.38350087 |
| 64 | Gingivitis (HP:0000230) | 2.34267101 |
| 65 | Orchitis (HP:0100796) | 2.28308650 |
| 66 | Slow saccadic eye movements (HP:0000514) | 2.27348022 |
| 67 | Sudden death (HP:0001699) | 2.25323867 |
| 68 | Urticaria (HP:0001025) | 2.23984927 |
| 69 | Osteomyelitis (HP:0002754) | 2.22468608 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.22319400 |
| 71 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.21961104 |
| 72 | Viral hepatitis (HP:0006562) | 2.20275610 |
| 73 | Granulocytopenia (HP:0001913) | 2.18829083 |
| 74 | Hyporeflexia of lower limbs (HP:0002600) | 2.17997929 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.17968421 |
| 76 | Keratoconjunctivitis sicca (HP:0001097) | 2.14722311 |
| 77 | Neuronal loss in central nervous system (HP:0002529) | 2.11518542 |
| 78 | Arterial thrombosis (HP:0004420) | 2.10270344 |
| 79 | Hemoptysis (HP:0002105) | 2.09213836 |
| 80 | Fatigue (HP:0012378) | 2.09086734 |
| 81 | B lymphocytopenia (HP:0010976) | 2.09086662 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.09086662 |
| 83 | Leukocytosis (HP:0001974) | 2.07711643 |
| 84 | Periodontitis (HP:0000704) | 2.06116096 |
| 85 | Polygenic inheritance (HP:0010982) | 2.04058075 |
| 86 | Chronic sinusitis (HP:0011109) | 2.02770552 |
| 87 | Loss of speech (HP:0002371) | 2.02584256 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.02116986 |
| 89 | Retrobulbar optic neuritis (HP:0100654) | 2.02116375 |
| 90 | Optic neuritis (HP:0100653) | 2.02116375 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 2.02026550 |
| 92 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.01749173 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01648469 |
| 94 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01648469 |
| 95 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01648469 |
| 96 | Broad face (HP:0000283) | 2.00015465 |
| 97 | Systemic lupus erythematosus (HP:0002725) | 1.99514382 |
| 98 | Cerebral aneurysm (HP:0004944) | 1.99158251 |
| 99 | Distal lower limb amyotrophy (HP:0008944) | 1.97053037 |
| 100 | Increased IgE level (HP:0003212) | 1.96914410 |
| 101 | Muscle fiber inclusion bodies (HP:0100299) | 1.96694022 |
| 102 | EMG: myopathic abnormalities (HP:0003458) | 1.96087440 |
| 103 | Hypochromic anemia (HP:0001931) | 1.94806726 |
| 104 | Gingival bleeding (HP:0000225) | 1.94303526 |
| 105 | Sepsis (HP:0100806) | 1.93759100 |
| 106 | Facial diplegia (HP:0001349) | 1.93277533 |
| 107 | Increased serum ferritin (HP:0003281) | 1.92793708 |
| 108 | Myoglobinuria (HP:0002913) | 1.92208106 |
| 109 | IgA deficiency (HP:0002720) | 1.91929004 |
| 110 | Increased density of long bones (HP:0006392) | 1.91809285 |
| 111 | Epistaxis (HP:0000421) | 1.90802870 |
| 112 | Supranuclear gaze palsy (HP:0000605) | 1.90701257 |
| 113 | Interstitial pulmonary disease (HP:0006530) | 1.89756849 |
| 114 | Purpura (HP:0000979) | 1.89553262 |
| 115 | Dysmetric saccades (HP:0000641) | 1.89363593 |
| 116 | Metaphyseal cupping (HP:0003021) | 1.88842145 |
| 117 | Chronic diarrhea (HP:0002028) | 1.88658454 |
| 118 | Keratoconjunctivitis (HP:0001096) | 1.87622343 |
| 119 | Hemorrhage of the eye (HP:0011885) | 1.87419357 |
| 120 | Disinhibition (HP:0000734) | 1.87336783 |
| 121 | Eosinophilia (HP:0001880) | 1.85704102 |
| 122 | Axonal loss (HP:0003447) | 1.85527969 |
| 123 | Bundle branch block (HP:0011710) | 1.84957720 |
| 124 | Pulmonary embolism (HP:0002204) | 1.84795279 |
| 125 | Petechiae (HP:0000967) | 1.84637879 |
| 126 | Thrombocytosis (HP:0001894) | 1.84545439 |
| 127 | Amyloidosis (HP:0011034) | 1.84156723 |
| 128 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.83117260 |
| 129 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81614014 |
| 130 | Muscle fiber splitting (HP:0003555) | 1.81193948 |
| 131 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.80406156 |
| 132 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.80406156 |
| 133 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.80406156 |
| 134 | Mucopolysacchariduria (HP:0008155) | 1.80039193 |
| 135 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.80039193 |
| 136 | Hypertensive crisis (HP:0100735) | 1.79909352 |
| 137 | Papilledema (HP:0001085) | 1.77575729 |
| 138 | Increased connective tissue (HP:0009025) | 1.77150771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.06666285 |
| 2 | PRPF4B | 3.86845783 |
| 3 | TTN | 2.78356740 |
| 4 | RIPK4 | 2.77775416 |
| 5 | MAP3K13 | 2.65958610 |
| 6 | SIK2 | 2.60667649 |
| 7 | TYK2 | 2.48887975 |
| 8 | BLK | 2.48167544 |
| 9 | MAP3K10 | 2.46970151 |
| 10 | MAP3K14 | 2.41040689 |
| 11 | ERN1 | 2.18174287 |
| 12 | JAK3 | 2.11076151 |
| 13 | TRIB3 | 1.99695604 |
| 14 | SMG1 | 1.93135635 |
| 15 | JAK1 | 1.89575732 |
| 16 | TBK1 | 1.88886300 |
| 17 | CSF1R | 1.85089239 |
| 18 | KIT | 1.83930773 |
| 19 | SYK | 1.82453597 |
| 20 | FES | 1.69012743 |
| 21 | GRK6 | 1.68692823 |
| 22 | HCK | 1.58828589 |
| 23 | PKN2 | 1.56567407 |
| 24 | EPHB1 | 1.55916232 |
| 25 | BTK | 1.55519051 |
| 26 | IKBKE | 1.54787128 |
| 27 | CAMK1G | 1.54253719 |
| 28 | TXK | 1.52165787 |
| 29 | ZAP70 | 1.51722149 |
| 30 | ICK | 1.51288430 |
| 31 | EEF2K | 1.48623699 |
| 32 | TGFBR2 | 1.44851975 |
| 33 | IRAK3 | 1.40827119 |
| 34 | STK10 | 1.38315043 |
| 35 | IRAK4 | 1.37675636 |
| 36 | IKBKB | 1.36282953 |
| 37 | MAP3K7 | 1.33343381 |
| 38 | CAMK1D | 1.31931936 |
| 39 | MAP3K3 | 1.28464611 |
| 40 | CSK | 1.23727326 |
| 41 | MAP2K3 | 1.22364782 |
| 42 | LCK | 1.20215501 |
| 43 | ITK | 1.19407258 |
| 44 | CDK12 | 1.18171771 |
| 45 | MAP3K9 | 1.13051034 |
| 46 | DMPK | 1.08496122 |
| 47 | TAOK2 | 1.05308405 |
| 48 | OBSCN | 1.02562256 |
| 49 | LRRK2 | 1.01702055 |
| 50 | PTK6 | 1.01695318 |
| 51 | PHKG1 | 1.00464864 |
| 52 | PHKG2 | 1.00464864 |
| 53 | PRKCH | 0.98157733 |
| 54 | MAPK12 | 0.97788361 |
| 55 | ALK | 0.95333087 |
| 56 | JAK2 | 0.94776919 |
| 57 | CLK1 | 0.94774927 |
| 58 | PRKD2 | 0.93298124 |
| 59 | FGFR3 | 0.93115065 |
| 60 | PDK1 | 0.90172642 |
| 61 | TEC | 0.88065877 |
| 62 | LYN | 0.86751595 |
| 63 | MARK3 | 0.83179910 |
| 64 | RIPK1 | 0.81972007 |
| 65 | IRAK2 | 0.80784753 |
| 66 | CHUK | 0.80620426 |
| 67 | FGFR4 | 0.79431258 |
| 68 | CDK4 | 0.77251361 |
| 69 | TAOK1 | 0.76922327 |
| 70 | PRKCQ | 0.74940349 |
| 71 | MAPK11 | 0.69404757 |
| 72 | TNK2 | 0.67030804 |
| 73 | RET | 0.63268742 |
| 74 | HIPK2 | 0.61429178 |
| 75 | TYRO3 | 0.59603138 |
| 76 | IRAK1 | 0.57006591 |
| 77 | SGK3 | 0.56139479 |
| 78 | FGR | 0.55934615 |
| 79 | PIM1 | 0.55752135 |
| 80 | CAMKK1 | 0.55644335 |
| 81 | PRKD1 | 0.54521710 |
| 82 | GRK7 | 0.54094683 |
| 83 | PDPK1 | 0.53686933 |
| 84 | MTOR | 0.53259969 |
| 85 | MARK2 | 0.52770428 |
| 86 | RPS6KA2 | 0.52581485 |
| 87 | MAP3K6 | 0.51316803 |
| 88 | KSR2 | 0.51089404 |
| 89 | EPHA3 | 0.50183234 |
| 90 | CAMK4 | 0.50176984 |
| 91 | TAOK3 | 0.50135539 |
| 92 | YES1 | 0.49471635 |
| 93 | MAPK7 | 0.49407832 |
| 94 | BMX | 0.48174069 |
| 95 | MAP2K2 | 0.47892592 |
| 96 | STK11 | 0.46658612 |
| 97 | FYN | 0.46107220 |
| 98 | PKN1 | 0.45790667 |
| 99 | EGFR | 0.45768954 |
| 100 | DYRK1B | 0.44720482 |
| 101 | CDK6 | 0.44106538 |
| 102 | MAP3K8 | 0.42914827 |
| 103 | BRD4 | 0.42086609 |
| 104 | SIK3 | 0.41818790 |
| 105 | RPS6KA6 | 0.40276045 |
| 106 | STK4 | 0.39956742 |
| 107 | BMPR2 | 0.39891654 |
| 108 | MAPK4 | 0.39701425 |
| 109 | PRKAA2 | 0.38146285 |
| 110 | MAP2K6 | 0.37665570 |
| 111 | TRPM7 | 0.37602421 |
| 112 | CAMK1 | 0.37032317 |
| 113 | WNK1 | 0.36785494 |
| 114 | SIK1 | 0.35647798 |
| 115 | NME2 | 0.34928413 |
| 116 | PIK3CG | 0.34055590 |
| 117 | MAPKAPK2 | 0.33662857 |
| 118 | ABL1 | 0.33392058 |
| 119 | DAPK2 | 0.32913861 |
| 120 | MAP3K1 | 0.30415162 |
| 121 | MAP3K11 | 0.30184786 |
| 122 | CDC42BPA | 0.29880337 |
| 123 | CAMKK2 | 0.29566706 |
| 124 | RPS6KL1 | 0.29367050 |
| 125 | RPS6KC1 | 0.29367050 |
| 126 | MATK | 0.28078546 |
| 127 | PAK6 | 0.27945909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.37583213 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.90901726 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.49698902 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.34280777 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12103269 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.02434381 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.94426421 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.89263277 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.87960325 |
| 10 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.76938615 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70140015 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.68547738 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.68074017 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64769269 |
| 15 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.63904545 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59928807 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.59652863 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51660709 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51485136 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45846789 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37979877 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34997622 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34779426 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33845998 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.29455503 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.28484557 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27685199 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.26977940 |
| 29 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.26775092 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.26402133 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.24617322 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23578812 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.20013112 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.18727122 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14695663 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14422503 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13390855 |
| 38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.11824726 |
| 39 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.11596098 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.08689188 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.07196384 |
| 42 | Insulin resistance_Homo sapiens_hsa04931 | 1.03796751 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.01616764 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00046854 |
| 45 | Malaria_Homo sapiens_hsa05144 | 0.99864734 |
| 46 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99216425 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98899998 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.97483550 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97006020 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96385412 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.94999786 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93447070 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.92668647 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.92060387 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91692216 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.89222764 |
| 57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.88836196 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86315797 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.85719036 |
| 60 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84500778 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.83816440 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.83754525 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83415407 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.82351516 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78997788 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78988329 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78618929 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.77788770 |
| 69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77415192 |
| 70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77306771 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.76047002 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76045355 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75939741 |
| 74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.75722929 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75134183 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75047290 |
| 77 | Olfactory transduction_Homo sapiens_hsa04740 | 0.74254406 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72822114 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.71609409 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.69274212 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68798162 |
| 82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68345961 |
| 83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.68312094 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68152597 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67801232 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.67754481 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67460851 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.66994522 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66563555 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64734178 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63802253 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.63080664 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | 0.62592181 |
| 94 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61879366 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61707264 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61510424 |
| 97 | Morphine addiction_Homo sapiens_hsa05032 | 0.61363062 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.61259342 |
| 99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60965412 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60768200 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.60384016 |
| 102 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60300454 |
| 103 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59979348 |
| 104 | Renin secretion_Homo sapiens_hsa04924 | 0.59957774 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59628529 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59568595 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58453165 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58375577 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.58304300 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57669113 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57270782 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57029807 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56792294 |
| 114 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.56682801 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56440944 |
| 116 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54172699 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51790328 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51344208 |

